KRISHNAN MAHESH sold 33.6% of their position (7.30K shares) of HALOZYME THERAPEUTICS, INC. on the open market
Open‑market sale worth $547.8K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/30/2026ACC: 0001159036-26-000082
Director
Since Apr 2024
-7.30K
Net shares
Net seller
$547.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
7.30K acquired · 14.61K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.30K
Price / share
$38.46
Trade value
$280.91K
% of position
50.5%
6/29/2026
14.46K→21.77K
Common Stock
Direct
Shares
−7.30K
Price / share
$75.00
Trade value
$547.80K
% of position
33.6%
6/29/2026
21.77K→14.46K
Total
Net shares
+0.00
Net value
-$266.89K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/29/2026 | M · Option Exercise | +7.30K | $38.46 | $280.91K | 50.5% | 14.46K | 21.77K |
| Common Stock Direct | 6/29/2026 | S · Sale | −7.30K | $75.00 | $547.80K | 33.6% | 21.77K | 14.46K |
| Total | +0.00 | -$266.89K | ||||||
Derivative Transactions1
Option to Purchase Common Stock
Direct
Converts to
Common Stock
7.30K shares
Shares
−7.30K
Strike price
38.46
Held after
1.50K
Exercisable
—
6/29/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock7.30K shares | 6/29/2026 | M · Option Exercise | −7.30K | 38.46 | — | 1.50K |